跳至主要内容
临床试验/JPRN-UMIN000017804
JPRN-UMIN000017804已完成2 期

The study of fosaprepitant in the prevention of chemotherapy induced nausea and vomiting in patients with gynecologic cancer undergoing the combination therapy of Taxens and carboplatin. - The study of fosaprepitant in the prevention of chemotherapy induced nausea and vomiting in patients with gynecologic cancer undergoing the combination therapy of Taxens and carboplatin.

Saitama Medical University International Medical Center0 个研究点目标入组 50 人开始时间: 2015年6月5日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1)The patient who is complicated with a serious liver damage or a renal damage. 2)A pregnant woman and the patient who may be pregnant now. 3)A patient with past hypersensitivity of fosaprepitant and/or ingredient of aprepitant. 4)A patient using Pimozide. 5)A patient using steroids. 6)Patients who were determined unsuitable for this study by medical doctors.

研究者

相似试验